Therefore, a link between breast cancer and MEN1 may not necessarily be directly related to a pathogenic MEN1 variant but rather to an MEN1 clinical manifestation such as prolactinoma, hyperparathyroidism, or insulinoma. This evidence concerns the gene MEN1 and breast carcinoma.